Shelton Capital Management Abb Vie Inc. Transaction History
Shelton Capital Management
- $3.85 Billion
- Q3 2024
A detailed history of Shelton Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Shelton Capital Management holds 92,980 shares of ABBV stock, worth $16.3 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
92,980
Previous 125,641
26.0%
Holding current value
$16.3 Million
Previous $21.5 Million
14.79%
% of portfolio
0.48%
Previous 0.6%
Shares
33 transactions
Others Institutions Holding ABBV
# of Institutions
3,855Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.9 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.16 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.78 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $310B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...